The Fund will invest at least 80% of its net assets (plus any borrowings for investment purposes) in investments that provide exposure to equity securities issued by large-capitalization U.S.
NEW YORK, July 17 (Praxis Press) Magnetic resonance cholangiopancreatography (MRCP) is a promising alternative to endoscopic retrograde cholangiopancreatography (ERCP), but its accuracy has not been ...